August 2022 Edition

August 7, 2022

Clinical News

Lorazepam Injection Drug Shortage

A national supply disruption has caused an interruption in the dependable availability of lorazepam injection products – a benzodiazepine used for status epilepticus and as a pre-op medication for the relief of anxiety and tension.

Read More

Successful Treatment of Stage II and III Rectal Cancer with Dostarlimab

A small group of patients with locally advanced, mismatch repair-deficient rectal cancer showed a complete response to dostarlimab and have not required further treatment.

Read More

Paxlovid Clinical Refresher to Minimize Med Errors

Check out this updated guide on the use of Paxlovid to treat people with mild to moderate Covid symptoms.

Read More

PharMerica’s Inaugural Opioid Stewardship Program (OSP) Now Available

Promote optimal pain management practices and judicious opioid stewardship in your facility with this comprehensive toolkit and implementation guide. The program outlines the core elements of medication stewardship and provides a stepwise process for adopting opioid stewardship practices, with sample leadership statements, policies & procedures, educational materials, and more. Contact your Account Manager for more information today!

Read More


Did You Know?

Fact sheets and instructions for easy reference by clinical staff

Check out our quick reference tools on insulin products:


Regulatory Updates

CMS Updates Released

Phase 3 of the Mega Rule is being implemented October 24, 2022. Here’s a reminder of what your facility needs to know to comply with the pharmacy-related requirements.

Read More


Upcoming Events

All Aboard! Staying on Track to Optimize Psychotropic Medications

Wednesday, August 3 at 1PM ET / 12PM CT

Presented by:

  • Matthew J Palmer, BS, PharmD, BCGP, Manager of Clinical Operations, PharMerica
  • Nena Hart MSN, RN, CHPN, RAC-CT, C-DONA

Watch Live Recording

Episode 7: More MDS Coordinators are walking the floor. Is that a costly mistake?